ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
정밀의료 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 879억 1,000만 달러에서 2026년에는 962억 7,000만 달러에 이르고, CAGR 9.5%로 성장할 전망입니다. 지난 수년간의 성장 요인으로는 유전체 연구의 발전, 유전자 시퀀싱 비용의 감소, 암 및 유전성 질환의 유병률 증가, 바이오의약품 연구개발비용 증가, 표적치료제의 규제 승인 등을 꼽을 수 있습니다.
정밀의료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 1,376억 9,000만 달러에 이르고, CAGR은 9.4%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 차세대 염기서열 분석 기술의 보급 확대, 개인 맞춤형 치료 계획에 대한 수요 증가, AI 기반 신약 개발 활용 확대, 정밀 진단에 대한 투자 증가, 디지털 헬스 플랫폼의 통합 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 동반진단 도입 확대, 개인 맞춤형 암 치료로의 전환, 임상 의사결정에 있어 멀티오믹스 데이터 통합, 희귀질환 및 유전성 질환의 정밀의료 확대, 제약기업과 진단기업 간 협력 강화 등을 꼽을 수 있습니다.
암 발병률 증가는 정밀의료 시장의 성장을 가속할 것으로 예측됩니다. 암은 여전히 전 세계 주요 사망 원인 중 하나이며, 일생 동안 약 5명 중 1명이 발병하는 것으로 알려져 있습니다. 종양학에서 정밀의료는 종양 DNA를 분석하여 암 진행을 촉진하는 돌연변이 및 기타 유전적 이상을 확인합니다. 이를 통해 의사는 환자의 종양 고유 유전자 프로파일에 맞는 치료법을 선택할 수 있어 치료 효과와 예후를 개선할 수 있습니다. 예를 들어, 2024년 2월 스위스에 본부를 둔 전문 기관인 세계보건기구(WHO)가 발표한 예측에 따르면, 2050년까지 신규 암 환자 수는 3,500만 명을 넘어설 것으로 추산되며, 이는 2022년 추정 환자 수 2,000만 명에서 77% 증가한 수치입니다. 그 결과, 암 발생률 증가가 정밀의료 솔루션에 대한 수요를 견인하고 있습니다.
정밀의료 시장의 주요 기업들은 공공 데이터 세트에 대한 접근성 향상과 분석 효율을 높이기 위해 데이터 수집 플랫폼 등 기술 혁신에 집중하고 있습니다. 데이터 수집은 여러 소스에서 데이터를 수집하여 중앙 집중식 저장 및 처리 시스템으로 가져오는 과정을 말합니다. 예를 들어, 2023년 5월 미국 소프트웨어 개발 기업인 구글 클라우드(Google Cloud)는 신약개발과 정밀의료의 노력을 가속화하기 위해 고안된 두 가지 AI 기반 솔루션을 발표했습니다. 이러한 도구를 통해 연구자들은 유전체 데이터 분석과 단백질 구조 규명을 보다 효율적으로 수행하고, 신약 개발 워크플로우를 개선하고, 중요한 치료제 시장 출시 기간을 단축하며, 연구팀 간 및 멀티 클라우드 환경에서의 협업을 촉진할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Precision medicine is a type of treatment that prevents, detects, or manages disease by using information about an individual's genes or proteins. It takes into account a person's genetics, environment, and lifestyle to select the therapy most likely to be effective.
The main technologies used in precision medicine include bioinformatics, big data analytics, drug discovery, gene sequencing, companion diagnostics, and others. Bioinformatics applies computational tools to organize, analyze, interpret, visualize, and store data related to biological macromolecules. Precision medicine is applied in areas such as oncology, respiratory diseases, central nervous system disorders, immunology, genetic diseases, and more, and is implemented across sectors including pharmaceuticals, diagnostic companies, healthcare providers, and IT firms.
Tariffs have influenced the precision medicine market by increasing costs and supply chain complexities for gene sequencing instruments, diagnostic reagents, and bioinformatics hardware sourced globally. Higher import duties have particularly affected drug discovery, companion diagnostics, and gene sequencing segments, with Asia-Pacific and Europe experiencing notable impacts due to cross-border dependency on specialized components. Oncology and genomic testing applications face cost pressures that may slow adoption in price-sensitive healthcare systems. However, tariffs are also encouraging localized manufacturing, regional partnerships, and domestic innovation, supporting long-term supply resilience and technology self-sufficiency in key markets.
The precision medicine market research report is one of a series of new reports from The Business Research Company that provides precision medicine market statistics, including precision medicine industry global market size, regional shares, competitors with a precision medicine market share, detailed precision medicine market segments, market trends and opportunities, and any further data you may need to thrive in the precision medicine industry. This precision medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The precision medicine market size has grown strongly in recent years. It will grow from $87.91 billion in 2025 to $96.27 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to advancements in genomic research, declining cost of gene sequencing, increasing prevalence of cancer and genetic disorders, growth in biopharmaceutical R&D spending, regulatory approvals for targeted therapies.
The precision medicine market size is expected to see strong growth in the next few years. It will grow to $137.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expansion of next-generation sequencing adoption, rising demand for personalized treatment plans, growing use of ai-driven drug discovery, increasing investments in precision diagnostics, integration of digital health platforms. Major trends in the forecast period include rising adoption of companion diagnostics, shift toward personalized oncology therapies, integration of multi-omics data in clinical decision-making, expansion of precision medicine in rare and genetic diseases, increasing collaboration between pharma and diagnostic firms.
The rising prevalence of cancer is expected to propel the growth of the precision medicine market. Cancer remains one of the leading causes of death globally, with approximately one in five individuals developing the disease during their lifetime. Precision medicine in oncology involves analyzing tumor DNA to identify mutations or other genetic abnormalities driving cancer progression. This allows physicians to select therapies tailored to the unique genetic profile of a patient's tumor, improving treatment efficacy and outcomes. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency, over 35 million new cancer cases are projected by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing incidence of cancer is driving demand for precision medicine solutions.
Major companies in the precision medicine market are emphasizing technological innovations, such as data ingestion platforms, to enhance access to public datasets and streamline analytics. Data ingestion refers to the process of collecting and importing data from multiple sources into a centralized storage or processing system. For example, in May 2023, Google Cloud, a US-based software development company, launched two AI-powered solutions designed to accelerate drug discovery and precision medicine initiatives. These tools enable researchers to interpret genomic data and identify protein structures more efficiently, improving drug development workflows, shortening time-to-market for critical therapies, and facilitating collaboration across research teams and multi-cloud environments.
In July 2024, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Olink Proteomics for an undisclosed amount. This acquisition expands Thermo Fisher's capabilities in proteomics-the large-scale study of proteins-which plays a crucial role in precision medicine. Olink Proteomics, a Sweden-based biotechnology company, contributes innovative technologies and services focused on protein biomarker analysis, supporting targeted therapies and personalized treatment approaches.
Major companies operating in the precision medicine market are Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co. Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co.Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, Uniao Quimica
North America was the largest region in the precision medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the precision medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The precision medicine market consists of sales of imatinib, personalized medicine, and individualized medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Precision Medicine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses precision medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for precision medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision medicine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Technology: Big Data Analytics; Bioinformatics; Gene Sequencing; Drug Discovery; Companion Diagnostics; Other Technology
2) By Application: Oncology; Respiratory Diseases; Central Nervous System Disorders; Immunology; Genetic Diseases; Other Applications.
3) By End-Use: Pharmaceutical Companies; Diagnostic Companies; Healthcare And IT Firms; Others
Subsegments:
1) By Big Data Analytics: Predictive Analytics; Prescriptive Analytics; Data Mining
2) By Bioinformatics: Genomic Data Analysis; Proteomics Data Analysis; Metabolomics Data Analysis
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.3 Integration Of Multi-Omics Data In Clinical Decision-Making
4.2.4 Expansion Of Precision Medicine In Rare And Genetic Diseases
4.2.5 Increasing Collaboration Between Pharma And Diagnostic Firms
5. Precision Medicine Market Analysis Of End Use Industries
5.1 Pharmaceutical Companies
5.2 Diagnostic Companies
5.3 Healthcare Providers And Hospitals
5.4 Research Institutes And Academic Centers
5.5 Biotechnology Companies
6. Precision Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Precision Medicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Precision Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Precision Medicine Market Size, Comparisons And Growth Rate Analysis
7.3. Global Precision Medicine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Precision Medicine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Precision Medicine Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Precision Medicine Market Segmentation
9.1. Global Precision Medicine Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology
9.2. Global Precision Medicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications
9.3. Global Precision Medicine Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others
9.4. Global Precision Medicine Market, Sub-Segmentation Of Big Data Analytics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Predictive Analytics, Prescriptive Analytics, Data Mining
9.5. Global Precision Medicine Market, Sub-Segmentation Of Bioinformatics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis
9.6. Global Precision Medicine Market, Sub-Segmentation Of Gene Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Precision Medicine Market, Sub-Segmentation Of Drug Discovery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials
9.8. Global Precision Medicine Market, Sub-Segmentation Of Companion Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Precision Medicine Market, Sub-Segmentation Of Other Technology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology
10. Precision Medicine Market Regional And Country Analysis
10.1. Global Precision Medicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Precision Medicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Precision Medicine Market
11.1. Asia-Pacific Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Precision Medicine Market
12.1. China Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Precision Medicine Market
13.1. India Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Precision Medicine Market
14.1. Japan Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Precision Medicine Market
15.1. Australia Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Precision Medicine Market
16.1. Indonesia Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Precision Medicine Market
17.1. South Korea Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Precision Medicine Market
18.1. Taiwan Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Precision Medicine Market
19.1. South East Asia Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Precision Medicine Market
20.1. Western Europe Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Precision Medicine Market
21.1. UK Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Precision Medicine Market
22.1. Germany Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Precision Medicine Market
23.1. France Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Precision Medicine Market
24.1. Italy Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Precision Medicine Market
25.1. Spain Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Precision Medicine Market
26.1. Eastern Europe Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Precision Medicine Market
27.1. Russia Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Precision Medicine Market
28.1. North America Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Precision Medicine Market
29.1. USA Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Precision Medicine Market
30.1. Canada Precision Medicine Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Precision Medicine Market
31.1. South America Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Precision Medicine Market
32.1. Brazil Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Precision Medicine Market
33.1. Middle East Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Precision Medicine Market
34.1. Africa Precision Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Precision Medicine Market, Segmentation By Technology, Segmentation By Application, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Precision Medicine Market Regulatory and Investment Landscape
36. Precision Medicine Market Competitive Landscape And Company Profiles
36.1. Precision Medicine Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Precision Medicine Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Precision Medicine Market Company Profiles
36.3.1. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
37. Precision Medicine Market Other Major And Innovative Companies
Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co. Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co. Ltd.
38. Global Precision Medicine Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Precision Medicine Market
40. Precision Medicine Market High Potential Countries, Segments and Strategies
40.1 Precision Medicine Market In 2030 - Countries Offering Most New Opportunities
40.2 Precision Medicine Market In 2030 - Segments Offering Most New Opportunities
40.3 Precision Medicine Market In 2030 - Growth Strategies
